PRGO
PRGO clinical trials: PERRIGO Co plc
Every trial on ClinicalTrials.gov where PERRIGO Co plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 7
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PRGO on the catalyst calendar · PRGO registry changes
- Primary completion Apr 2016ActualPhase 3NCT01744106A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common ColdPerrigo Company · Nasal Congestion Associated With the Common Cold
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2004ActualPhase 1NCT00804440Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting ConditionsPerrigo Company · BioequivalencyCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2004ActualPhase 1NCT00804401Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting ConditionsPerrigo Company · BioequivalencyCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2003ActualPhase 1NCT00803946Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed ConditionsPerrigo Company · BioequivalencyCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2004ActualPhase 1NCT00803764Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed ConditionsPerrigo Company · BioequivalencyCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2004ActualPhase 1NCT00803192Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed ConditionsPerrigo Company · BioavailabilityCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2004ActualPhase 1NCT00802828Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting ConditionsPerrigo Company · BioavailabilityCompletedPRGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 22, 2022Sponsor estimateNo phase registeredNCT04801134Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 PandemicUniversity of Texas at Austin · Food InsecurityUnknown statusPRGOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2021Sponsor estimatePhase 1/Phase 2NCT03518268Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase InhibitorTel-Aviv Sourasky Medical Center · Breast CancerUnknown statusPRGOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2011ActualPhase 4NCT01257542Acute Cough Study In ChildrenPfizer · Common ColdTerminatedPFELeadNVSCollaboratorPRGOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner